# HireQuest, Inc.: financial statements, quarterly

HQI · Nasdaq · CIK 1140102 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hqi.md) · [Financials](/companies/hqi/financials.md) · [Filings](/companies/hqi/filings.md) · [Insiders](/companies/hqi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hqi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [9,271](/filings/0001437749-24-034020.md) | [9,764 d](/filings/0001437749-25-009646.md) | [8,419](/filings/0001437749-25-015543.md) | [8,680](/filings/0001437749-25-025485.md) | [9,416](/filings/0001437749-25-033646.md) | [8,083 d](/filings/0001437749-26-010435.md) | [7,472](/filings/0001437749-26-016462.md) | [7,638](/filings/0001437749-26-026819.md) | [8,497](/filings/0001437749-25-033646.md) | [7,032 d](/filings/0001437749-26-010435.md) | [6,523](/filings/0001437749-26-016462.md) | [8,099](/filings/0001437749-26-026819.md) |
| Cost of revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $k | [6,354](/filings/0001437749-24-034020.md) | [6,624 d](/filings/0001437749-25-009646.md) | [5,619](/filings/0001437749-25-015543.md) | [5,288](/filings/0001437749-25-025485.md) | [5,379](/filings/0001437749-25-033646.md) | [5,120 d](/filings/0001437749-26-010435.md) | [5,255](/filings/0001437749-26-016462.md) | [5,861](/filings/0001437749-26-026819.md) | [5,070](/filings/0001437749-25-033646.md) | [4,489 d](/filings/0001437749-26-010435.md) | [4,269](/filings/0001437749-26-016462.md) | [3,994](/filings/0001437749-26-026819.md) |
| Operating income | $k | [2,218](/filings/0001437749-24-034020.md) | [2,443 d](/filings/0001437749-25-009646.md) | [2,102](/filings/0001437749-25-015543.md) | [2,695](/filings/0001437749-25-025485.md) | [(2,695)](/filings/0001437749-25-033646.md) | [2,266 d](/filings/0001437749-26-010435.md) | [1,483](/filings/0001437749-26-016462.md) | [1,043](/filings/0001437749-26-026819.md) | [2,445](/filings/0001437749-25-033646.md) | [1,312 d](/filings/0001437749-26-010435.md) | [1,476](/filings/0001437749-26-016462.md) | [3,343](/filings/0001437749-26-026819.md) |
| Interest expense | $k | [302](/filings/0001437749-24-034020.md) | [231 d](/filings/0001437749-25-009646.md) | [243](/filings/0001437749-25-015543.md) | [253](/filings/0001437749-25-025485.md) | [268](/filings/0001437749-25-033646.md) | [160 d](/filings/0001437749-26-010435.md) | [144](/filings/0001437749-26-016462.md) | [71.0](/filings/0001437749-26-026819.md) | [63.0](/filings/0001437749-25-033646.md) | [30.0 d](/filings/0001437749-26-010435.md) | [8.0](/filings/0001437749-26-016462.md) | [30.0](/filings/0001437749-26-026819.md) |
| Income tax | $k | [518](/filings/0001437749-24-034020.md) | [(185) d](/filings/0001437749-25-009646.md) | [340](/filings/0001437749-25-015543.md) | [557](/filings/0001437749-25-025485.md) | [(725)](/filings/0001437749-25-033646.md) | [49.0 d](/filings/0001437749-26-010435.md) | [169](/filings/0001437749-26-016462.md) | [56.0](/filings/0001437749-26-026819.md) | [137](/filings/0001437749-25-033646.md) | [(262) d](/filings/0001437749-26-010435.md) | [264](/filings/0001437749-26-016462.md) | [684](/filings/0001437749-26-026819.md) |
| Net income | $k | [1,483](/filings/0001437749-24-034020.md) | [15.0 d](/filings/0001437749-25-009646.md) | [1,619](/filings/0001437749-25-015543.md) | [2,039](/filings/0001437749-25-025485.md) | [(2,207)](/filings/0001437749-25-033646.md) | [2,221 d](/filings/0001437749-26-010435.md) | [1,363](/filings/0001437749-26-016462.md) | [1,060](/filings/0001437749-26-026819.md) | [2,304](/filings/0001437749-25-033646.md) | [1,603 d](/filings/0001437749-26-010435.md) | [1,560](/filings/0001437749-26-016462.md) | [2,692](/filings/0001437749-26-026819.md) |
| Diluted EPS | $ per share | [0.11](/filings/0001437749-24-034020.md) | not reported | [0.12](/filings/0001437749-25-015543.md) | [0.15](/filings/0001437749-25-025485.md) | [(0.16)](/filings/0001437749-25-033646.md) | not reported | [0.10](/filings/0001437749-26-016462.md) | [0.08](/filings/0001437749-26-026819.md) | [0.16](/filings/0001437749-25-033646.md) | not reported | [0.11](/filings/0001437749-26-016462.md) | [0.19](/filings/0001437749-26-026819.md) |
| Basic EPS | $ per share | [0.11](/filings/0001437749-24-034020.md) | not reported | [0.12](/filings/0001437749-25-015543.md) | [0.15](/filings/0001437749-25-025485.md) | [(0.16)](/filings/0001437749-25-033646.md) | not reported | [0.10](/filings/0001437749-26-016462.md) | [0.08](/filings/0001437749-26-026819.md) | [0.17](/filings/0001437749-25-033646.md) | not reported | [0.11](/filings/0001437749-26-016462.md) | [0.20](/filings/0001437749-26-026819.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.1](/filings/0001437749-23-030989.md) | [1.3](/filings/0001437749-25-009646.md) | [1.6](/filings/0001437749-24-015745.md) | [0.6](/filings/0001437749-24-025594.md) | [1.6](/filings/0001437749-24-034020.md) | [2.2](/filings/0001437749-26-010435.md) | [2.1](/filings/0001437749-25-015543.md) | [2.7](/filings/0001437749-25-025485.md) | [1.1](/filings/0001437749-25-033646.md) | [3.9](/filings/0001437749-26-026819.md) | [1.0](/filings/0001437749-26-016462.md) | [1.6](/filings/0001437749-26-026819.md) |
| Current assets | $m | [56.2](/filings/0001437749-23-030989.md) | [51.5](/filings/0001437749-25-009646.md) | [55.1](/filings/0001437749-24-015745.md) | [57.7](/filings/0001437749-24-025594.md) | [58.0](/filings/0001437749-24-034020.md) | [49.2](/filings/0001437749-26-010435.md) | [50.6](/filings/0001437749-25-015543.md) | [51.8](/filings/0001437749-25-025485.md) | [53.9](/filings/0001437749-25-033646.md) | [48.3](/filings/0001437749-26-026819.md) | [51.8](/filings/0001437749-26-016462.md) | [55.3](/filings/0001437749-26-026819.md) |
| Total assets | $m | [105](/filings/0001437749-23-030989.md) | [104](/filings/0001437749-25-009646.md) | [106](/filings/0001437749-24-015745.md) | [108](/filings/0001437749-24-025594.md) | [103](/filings/0001437749-24-034020.md) | [94.0](/filings/0001437749-26-010435.md) | [93.7](/filings/0001437749-25-015543.md) | [94.3](/filings/0001437749-25-025485.md) | [94.9](/filings/0001437749-25-033646.md) | [88.2](/filings/0001437749-26-026819.md) | [91.1](/filings/0001437749-26-016462.md) | [93.4](/filings/0001437749-26-026819.md) |
| Current liabilities | $m | [37.1](/filings/0001437749-23-030989.md) | [35.7](/filings/0001437749-25-009646.md) | [37.1](/filings/0001437749-24-015745.md) | [37.0](/filings/0001437749-24-025594.md) | [34.7](/filings/0001437749-24-034020.md) | [24.1](/filings/0001437749-26-010435.md) | [23.3](/filings/0001437749-25-015543.md) | [23.3](/filings/0001437749-25-025485.md) | [22.4](/filings/0001437749-25-033646.md) | [15.3](/filings/0001437749-26-026819.md) | [19.3](/filings/0001437749-26-016462.md) | [20.2](/filings/0001437749-26-026819.md) |
| Total liabilities | $m | [42.2](/filings/0001437749-23-030989.md) | [41.1](/filings/0001437749-25-009646.md) | [42.1](/filings/0001437749-24-015745.md) | [42.2](/filings/0001437749-24-025594.md) | [39.7](/filings/0001437749-24-034020.md) | [29.2](/filings/0001437749-26-010435.md) | [28.2](/filings/0001437749-25-015543.md) | [28.3](/filings/0001437749-25-025485.md) | [27.1](/filings/0001437749-25-033646.md) | [19.9](/filings/0001437749-26-026819.md) | [23.8](/filings/0001437749-26-016462.md) | [24.5](/filings/0001437749-26-026819.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [63.0](/filings/0001437749-24-034020.md) | [62.7](/filings/0001437749-26-010435.md) | [63.9](/filings/0001437749-25-025485.md) | [65.4](/filings/0001437749-25-033646.md) | [62.9](/filings/0001437749-25-033646.md) | [64.8](/filings/0001437749-26-026819.md) | [65.6](/filings/0001437749-26-026819.md) | [66.0](/filings/0001437749-26-026819.md) | [67.8](/filings/0001437749-25-033646.md) | [68.3](/filings/0001437749-26-026819.md) | [67.3](/filings/0001437749-26-026819.md) | [68.9](/filings/0001437749-26-026819.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [2,013 d](/filings/0001437749-24-034020.md) | [8,836 d](/filings/0001437749-25-009646.md) | [(967)](/filings/0001437749-25-015543.md) | [188 d](/filings/0001437749-25-025485.md) | [4,161 d](/filings/0001437749-25-033646.md) | [8,657 d](/filings/0001437749-26-010435.md) | [1,854](/filings/0001437749-26-016462.md) | [2,557 d](/filings/0001437749-26-026819.md) | [1,035 d](/filings/0001437749-25-033646.md) | [6,600 d](/filings/0001437749-26-010435.md) | [250](/filings/0001437749-26-016462.md) | [1,600 d](/filings/0001437749-26-026819.md) |
| Dividends paid | $k | [836 d](/filings/0001437749-23-030989.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.7](/filings/0001437749-23-007413.md) | [13.8](/filings/0001437749-24-015745.md) | [13.8](/filings/0001437749-24-025594.md) | [13.8](/filings/0001437749-24-034020.md) | [13.9](/filings/0001437749-25-015543.md) | [13.9](/filings/0001437749-25-025485.md) | [13.8](/filings/0001437749-25-033646.md) | [14.0](/filings/0001437749-26-016462.md) | [14.0](/filings/0001437749-26-026819.md) | [14.0](/filings/0001437749-25-033646.md) | [13.9](/filings/0001437749-26-016462.md) | [13.8](/filings/0001437749-26-026819.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,900,000 at 2026-08-10, from the cover of the [10-Q filed 2026-08-11](/filings/0001437749-26-026819.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.